Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Willsher

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapyS M Tan, K L Cheung, P C Willsher, et al.
Breast Cancer Research and Treatment|January 1, 1996
Prognostic significance of serum c-erbB-2 protein in breast cancer patientsP C Willsher, J Beaver, S Pinder, et al.
Breast Cancer Research and Treatment|March 23, 2001
Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancerF S Kenny, P C Willsher, J M Gee, et al.
International Journal of Cancer|February 13, 1999
Endocrine response and resistance in breast cancer: a role for the transcription factor FosJ M Gee, P C Willsher, F S Kenny, et al.
Anticancer Research|May 1, 1997
Male breast cancer: pathological and immunohistochemical featuresP C Willsher, I H Leach, I O Ellis, et al.
Breast Cancer Research and Treatment|December 5, 1997
Predictors of response to second-line endocrine therapy for breast cancerK L Cheung, P C Willsher, S E Pinder, et al.
Anticancer Research|December 17, 1998
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancerP C Willsher, S E Pinder, J M Gee, et al.
Anticancer Research|March 1, 1996
The significance of p53 autoantibodies in the serum of patients with breast cancerP C Willsher, S E Pinder, L Robertson, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapyS M Tan, K L Cheung, P C Willsher, et al.
Breast Cancer Research and Treatment|January 1, 1996
Prognostic significance of serum c-erbB-2 protein in breast cancer patientsP C Willsher, J Beaver, S Pinder, et al.
Breast Cancer Research and Treatment|March 23, 2001
Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancerF S Kenny, P C Willsher, J M Gee, et al.
International Journal of Cancer|February 13, 1999
Endocrine response and resistance in breast cancer: a role for the transcription factor FosJ M Gee, P C Willsher, F S Kenny, et al.
Anticancer Research|May 1, 1997
Male breast cancer: pathological and immunohistochemical featuresP C Willsher, I H Leach, I O Ellis, et al.
Breast Cancer Research and Treatment|December 5, 1997
Predictors of response to second-line endocrine therapy for breast cancerK L Cheung, P C Willsher, S E Pinder, et al.
Anticancer Research|December 17, 1998
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancerP C Willsher, S E Pinder, J M Gee, et al.
Anticancer Research|March 1, 1996
The significance of p53 autoantibodies in the serum of patients with breast cancerP C Willsher, S E Pinder, L Robertson, et al.
Pageof 3